---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-072064"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:35:01.860798+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sarepta CEO Douglas Ingram to retire by end of 2026; successor search underway

## Summary
- CEO Douglas Ingram notified retirement by end of 2026 or upon appointment of replacement.
- Board has commenced search for successor, considering internal and external candidates.
- Ingram will remain CEO until successor is appointed or through 2026.

## SEC filing metadata
- accession: 0001193125-26-072064
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312526072064/0001193125-26-072064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312526072064/srpt-20260225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-072064
- JSON: https://secwatch.observer/filing/0001193125-26-072064.json
- Plain text: https://secwatch.observer/filing/0001193125-26-072064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.